These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 11156525
1. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Saaristo A, Karpanen T, Alitalo K. Oncogene; 2000 Dec 11; 19(53):6122-9. PubMed ID: 11156525 [Abstract] [Full Text] [Related]
2. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G. J Clin Invest; 2002 Mar 11; 109(6):777-85. PubMed ID: 11901186 [Abstract] [Full Text] [Related]
3. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Eggert A, Ikegaki N, Kwiatkowski J, Zhao H, Brodeur GM, Himelstein BP. Clin Cancer Res; 2000 May 11; 6(5):1900-8. PubMed ID: 10815914 [Abstract] [Full Text] [Related]
12. Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma. Mitsuhashi N, Shimizu H, Ohtsuka M, Wakabayashi Y, Ito H, Kimura F, Yoshidome H, Kato A, Nukui Y, Miyazaki M. Hepatology; 2003 May 11; 37(5):1105-13. PubMed ID: 12717391 [Abstract] [Full Text] [Related]
13. Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells. Hangai M, Murata T, Miyawaki N, Spee C, Lim JI, He S, Hinton DR, Ryan SJ. Invest Ophthalmol Vis Sci; 2001 Jun 11; 42(7):1617-25. PubMed ID: 11381069 [Abstract] [Full Text] [Related]
14. Angiopoietin-1 and vascular endothelial growth factor expression in human esophageal cancer. Nagata J, Kijima H, Hatanaka H, Tokunaga T, Kamochi J, Abe Y, Takagi A, Mine T, Yamazaki H, Nakamura M, Ueyama Y. Int J Mol Med; 2002 Oct 11; 10(4):423-6. PubMed ID: 12239588 [Abstract] [Full Text] [Related]
15. Endothelial survival factors as targets for antineoplastic therapy. Reinmuth N, Stoeltzing O, Liu W, Ahmad SA, Jung YD, Fan F, Parikh A, Ellis LM. Cancer J; 2001 Oct 11; 7 Suppl 3():S109-19. PubMed ID: 11779081 [Abstract] [Full Text] [Related]
16. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain. Péoch M, Farion R, Hiou A, Le Bas JF, Pasquier B, Rémy C. Anticancer Res; 2002 Oct 11; 22(4):2147-51. PubMed ID: 12174896 [Abstract] [Full Text] [Related]
17. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy. Wood JM. Medicina (B Aires); 2000 Oct 11; 60 Suppl 2():41-7. PubMed ID: 11188930 [Abstract] [Full Text] [Related]
18. The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer. Lantzsch T, Hefler L, Krause U, Kehl A, Goepel C, Koelbl H, Dunst J, Lampe D. Anticancer Res; 2002 Oct 11; 22(3):1925-8. PubMed ID: 12168895 [Abstract] [Full Text] [Related]
19. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer. Stimpfl M, Tong D, Fasching B, Schuster E, Obermair A, Leodolter S, Zeillinger R. Clin Cancer Res; 2002 Jul 11; 8(7):2253-9. PubMed ID: 12114428 [Abstract] [Full Text] [Related]
20. [Breast cancer angiogenesis]. Toi M, Tominaga T. Gan To Kagaku Ryoho; 1996 May 11; 23(6):659-66. PubMed ID: 8645013 [Abstract] [Full Text] [Related] Page: [Next] [New Search]